Bio-Techne has been focused on protecting inventions in United States(US) with ten publications in Q2 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 47% filings and 25% grants. The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and China(CN) patent Office are among the top ten patent offices where Bio-Techne is filings its patents. Among the top granted patent authorities, Bio-Techne has 38% of its grants in European Patent Office(EPO), 25% in United States(US) and 25% in China(CN).

In terms of grant share, Bio-Techne stands in fifth position among its competitors. and secured the top positions according to recent patent publication data.

Patents related to rare diseases and Covid-19 lead Bio-Techne's portfolio

Bio-Techne has the highest number of patents in rare diseases followed by, Covid-19 and genomics. For rare diseases, nearly 50% of patents were filed and no patents were granted in Q2 2024.

Severe acute respiratory syndrome (sars) related patents lead Bio-Techne portfolio followed by image management, and leukemia

Bio-Techne has highest number of patents in severe acute respiratory syndrome (sars) followed by image management, leukemia, cyst.

For comprehensive analysis of Bio-Techne's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.